BDW568
Based on 1 Customer Validation
BDW568 is a selective STINGA230 agonist with an EC50 of 5.7 μM. BDW568 triggers the interferon signaling pathway and induces the expression of interferon-stimulated genes including MX1 and OAS1. BDW568 is applicable for cancer-related research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.4%
- CAS 番号: 335401-44-0
- 分子式: C12H12N4O2S2
- 分子量:308.38
-
保管条件:
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
BDW568 activates the STINGA230-mediated type I interferon signaling pathway in THP-1 cells, with an EC50 of 5.7 μM[2].
BDW568 (50 μM; 6 h) significantly upregulates the expression of MX1 and OAS1 in THP-1 cells[2].
BDW568 (serial dilution; 48 h) potently activates the STING pathway in THP-1 cells expressing STINGHAQ, with an EC50 of 5.7 μM[3].
BDW568 (50 μM; 6 h) significantly upregulates the interferon-stimulated genes MX1 and OAS1 in THP-1 cells expressing STINGHAQ[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:THP-1 cells (homozygous STINGHAQ genotype)
-
Concentration:50 μM
-
Incubation Time:6 h
-
Result:Induced elevated expression of ISGs MX1 and OAS1, with MX1 showing a relative mRNA expression level ~100-fold higher than mock-treated cells.
-
Cell Line:THP-1 cells (homozygous STINGHAQ)
-
Concentration:50 μM
-
Incubation Time:6 h
-
Result:Robustly elevated MX1 and OAS1 mRNA expression relative to vehicle-treated cells.
化学情報
-
CAS 番号 335401-44-0
-
性状 Solid
-
分子量 308.38
-
分子式 C12H12N4O2S2
-
Color White to off-white
-
SMILES
COC(CSC1=NN=C2N1C=NC3=C2C(C)=C(C)S3)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, sealed storage, away from moisture and light
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
純度とドキュメンテーション
-
データシート (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
[1]. Ling X, et al. Innovative CRISPR Screening Promotes Drug Target Identification. ACS Cent Sci. 2022 Nov 23;8(11):1477-1479. [Content Brief]
[2]. Tang Z, et al. Structural Evaluations of a Selective Human STINGA230 Agonist and Its Use in Macrophage Immunotherapies. ACS Med Chem Lett. 2024;15(5):653-658. Published 2024 Apr 12. [Content Brief]
[3]. Tang Z, et al. Structural and Biological Evaluations of a Non-Nucleoside STING Agonist Specific for Human STINGA230 Variants. bioRxiv [Preprint]. 2023 Jul 10:2023.07.02.547363. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
BDW568 関連分類
HY-162465 関連分類
Powered by Bioz